SightfileU.S. market data from official filings

VANDA PHARMACEUTICALS INC (VNDA)

Name: VANDA PHARMACEUTICALS INC (VNDA) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001347178 · EDGAR filings · Updated 2026-06-08

VANDA PHARMACEUTICALS INC (VNDA) has reported institutional ownership of 76.8%, with 169 institutional managers holding positions valued at $319.3M per the latest 13F reporting period.

Institutional ownership

76.8%

Institutional managers

169

Reported 13F value

$319.3M

Insider activity

21 trans.

−$2.69M net selling

Latest updates

2026-06-08 — Insider transaction reported (Form 4)
2026-06-08 — Insider transaction reported (Form 4)
2026-06-08 — Insider transaction reported (Form 4)
2026-06-08 — Insider transaction reported (Form 4)
2026-06-08 — Insider transaction reported (Form 4)
2026-06-08 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, VANDA PHARMACEUTICALS INC has 169 institutional holders and institutional ownership of 76.8%.

Insider activity

Insiders reported 21 transactions (4 buys, 7 sells) across 10 reporting insiders, with a net reported value of −$2.69M.

Related companies

OMEROS (OMER) · ATEA PHARMACEUTICALS INC (AVIR) · ENTRADA THERAPEUTICS INC (TRDA) · COMMUNITY HEALTH SYS INC NEW (CYH) · XOMA ROYALTY CORPORATION (XOMA) · ADC THERAPEUTICS SA (ADCT)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-08.